President of Mount Sinai Fuster Heart Hospital given top honor for his contributions to combating cardiovascular disease worldwide
The Cardiovascular Research Foundation® (CRF®) has announced New York Valves: The Structural Heart Summit will feature 12 Late-Breaking Clinical Trials and Science presentations. New York Valves 2024, the expanded iteration of our renowned annual Transcatheter Valve Therapy (TVT®) conference, will take place June 5-7, 2024, at the Jacob K. Javits Convention Center, North in New York City.
Current methods to model or correct mutations in live cells are inefficient, especially when multiplexing — installing multiple point mutations simultaneously across the genome. Researchers from the UC San Diego have developed new, efficient genome editing tools called multiplexed orthogonal base editors (MOBEs) to install multiple point mutations at once.
Rutgers Health researchers tie infertility treatment to a particular risk for hypertensive diseases.
Atrium Health Wake Forest Baptist and Forsyth County EMS have launched a program, believed to be the first in North Carolina, designed to improve outcomes for patients suffering from cardiac arrest.
A collaborative NIH-funded team is using AI to mine common chest CT scans to predict mortality. Their research identified a collection of cardiac factors that were predictive of death in a large group of patients, potentially setting the stage for improved cardiac screening.
Investigators from the Smidt Heart Institute at Cedars-Sinai are presenting more than 40 original research studies at the Heart Rhythm Society annual meeting in Boston, May 16-19.
The designation means OMC-Baton Rouge meets The Joint Commission's designation for readiness to treat patients who experience severe stroke.
One of the most common genetic heart diseases worldwide, hypertrophic cardiomyopathy (HCM) causes the walls of the left ventricle to become thick and stiff. In about 70 percent of cases, patients with HCM experience obstruction to blood flow, which increases pressures in the heart and can lead to chest pain, shortness of breath and reduced exercise capacity.
Researchers have discovered a protein marker to help identify cells able to repopulate in patients with damaged blood vessels. Their findings, recently published in Circulation, could lead to new therapies for people with endothelial dysfunction, a type of disorder that contributes to coronary artery disease that may occlude with plaque and lack ability to carry sufficient blood into the heart tissue causing a heart attack.
The first U.S. heart patient involved in a study for a new gene-editing therapy has successfully been treated at MedStar Washington Hospital Center.
Scientists have designed a new artificial intelligence model that emulates randomized clinical trials at determining the treatment options most effective at preventing stroke in people with heart disease.
NASSAU, Bahamas, April 26, 2024 /PRNewswire/ -- Roivios, a pioneering clinical-stage medical device company dedicated to transforming kidney health, is thrilled to announce it has been awarded the prestigious Breakthrough Device Designation by the U.S. Food and Drug Administration (FDA) for its cutting-edge JuxtaFlow® Renal Assist Device (RAD). This landmark recognition, fueled by the encouraging outcomes of the BIPASS-AKI feasibility study, coincides with the unveiling of pioneering research at the Society of Cardiovascular Anesthesiologists (SCA) Annual Meeting. It marks a significant leap forward in safeguarding kidney function for patients undergoing cardiac surgeries, addressing a key challenge in cardiothoracic surgery and critical care.
A multicenter study led by Vanderbilt University Medical Center (VUMC) and Lipscomb University College of Pharmacy in Nashville has identified a potential new treatment for acute heart failure, a leading cause of hospitalization and death.
The American Heart Association has named MedStar Washington Hospital Center Cardiologist Reginald Robinson, MD, its 2024 Physician of the Year. Dr. Robinson has more than two decades of service and leadership with AHA and has worked in the field of cardiology to improve the care of patients and the community.
Surgeons from the Smidt Heart Institute at Cedars-Sinai will be attending the American Association for Thoracic Surgery (AATS) Annual Meeting April 27-30 in Toronto and are available to discuss the latest cardiac surgery news and research.
As patients with congenital heart diseases live longer, researchers are attempting to understand some of the other complications they may face as they age. In a new study, a team from Children’s Hospital of Philadelphia (CHOP) used state-of-the-art technologies to understand the underlying biology of Fontan-associated liver disease (FALD).
An intricate simulation performed by UT Southwestern Medical Center researchers using one of the world’s most powerful supercomputers sheds new light on how proteins called SNAREs cause biological membranes to fuse.
In what is the largest, most ethnically diverse long-term study of a U.S. population, a University of California, Irvine research team found that an under-recognized genetic cholesterol-like particle called lipoprotein(a) can predict future cardiovascular disease.
A recent study by Case Western Reserve University used national data from U.S. military veterans with diabetes to validate and modify a widely accepted model used to predict the risk of heart failure in diabetic patients.
Columbia Engineers unveiled BeatProfiler, a groundbreaking new tool-- a comprehensive software that automates the analysis of heart cell function from video data. It's the first system to integrate the analysis of different heart function indicators into one tool, speeding up the process significantly and reducing the chance for errors.
The John Ochsner Heart & Vascular Institute brings an advancement in the treatment of heart rhythm disorders to the New Orleans and Gulf South region utilizing a new cardiac ablation procedure, the FARAPULSE Pulse Field Ablation System.
UC Davis Medical Center has become the first hospital in Western U.S. to perform a successful transcatheter tricuspid valve repair procedure with a groundbreaking catheter.
The American College of Cardiology has recognized Hackensack Meridian Mountainside Medical Center for its demonstrated expertise and commitment in treating patients who come to a cardiac cath lab for care, including diagnostic catheterizations and percutaneous coronary intervention (PCI) procedures
Hackensack University Medical Center Structural Heart team is among the highest-volume MitraClip groups in the nation, with success rates and outcomes that exceed national averages.
Breakthrough study led by Mount Sinai researcher could change standard-of-care guidelines to improve outcomes
Mount Sinai-led study identifies type of heart failure for which device may be most useful
The Cardiovascular Research Foundation (CRF) is excited to introduce New York Valves: The Structural Heart Summit, the expanded next iteration of our renowned annual Transcatheter Valve Therapy (TVT) conference.
Around 10% of all deaths following percutaneous coronary intervention are potentially preventable, a study led by Michigan Medicine finds.
Study examined 30-year trends in cardiovascular health using a suite of income equity metrics to provide a comprehensive picture of cardiovascular income inequity
This study, led by investigators in the Smidt Heart Institute at Cedars-Sinai, applies novel artificial intelligence (AI) methods to measure heart function.
When someone has a heart attack or a stroke, specialized care can give them the best chance of surviving.
A study conducted in University Hospitals of Leicester NHS Trust explored the potential of artificial intelligence (AI) in predicting the risk of lethal heart rhythm disturbances, known as ventricular arrhythmias (VA).
A recent study presented at the American College of Cardiology’s Annual Scientific Session has unveiled startling findings regarding the association between alcohol consumption and the risk of coronary heart disease, particularly among young to middle-aged women.
While pacemakers have been instrumental in treating many patients with heart rhythm disorders, their bulky design and dependence on wires can limit their usefulness and poses a risk of heart damage or infection. Researchers have cut the cords, shrunk the size, and expanded the capabilities of current designs.
Experts advance models for speedy adoption for better diagnosis and therapy in The Lancet.
B-type natriuretic peptide (BNP) plays a key role in chronic itch severity and can help to identify certain types of itch with a simple blood test, according to a new study led by Gil Yosipovitch, M.D., director of the Miami Itch Center, and Santosh Mishra, Ph.D., a neuroscientist and associate professor at the North Carolina State College of Veterinary Medicine.
Media registration is now open for TCT 2024 (Transcatheter Cardiovascular Therapeutics), the annual scientific symposium of the Cardiovascular Research Foundation (CRF).
Black patients in need of a heart transplant may be less likely to receive one than white patients, according to a new study led by Indiana University School of Medicine researchers.
A new study conducted in cell cultures showed that cholesterol-lowering drugs help to dampen the inflammation associated with periodontal disease by altering the behavior of macrophages, a type of immune cell.
UC San Diego Health is the first in San Diego to implant the world’s first dual chamber, leadless pacemaker system to help treat abnormal heart rhythms.
The program increases much-needed access to surgical treatment for youth with obesity
A new study examining cholesteryl esters suggests that periods of prolonged inactivity may affect people differently depending on their age.
RSS
Medicine keyboard_arrow_right
Sciencekeyboard_arrow_right
Life keyboard_arrow_right
Business keyboard_arrow_right
Journal News keyboard_arrow_right
By Location keyboard_arrow_right
Meetings, Grants, and Events keyboard_arrow_right
